DIANE KECSKES: Open Payments
NPI 1649208638 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,428 in 40 payments from 7 companies in 2025. Trend: 2023 $1,883 · 2024 $1,120 · 2025 $1,428
Food & beverage: $1,428
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $413 |
| E.R. Squibb & Sons, L.L.C. | 3 | $259 |
| Alkermes, Inc. | 3 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $163 |
| Otsuka America Pharmaceutical, Inc. | 2 | $138 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
Products named: INGREZZA, COBENFY, CAPLYTA, FANAPT, INVEGA SUSTENNA, ABILIFY MAINTENA, ARISTADA, LYBALVI.
Industry payments across CA — which companies pay providers there.
